Skip to main content
. 2012 Mar 29;106(9):1469–1474. doi: 10.1038/bjc.2012.100

Table 3. Tumour response according to the treatment group.

  DS arm ( n =56) D arm ( n =49) Total ( n =105)
Best response (N, %)
 Complete response 1 (1.8) 0 (0.0) 1 (1.0)
 Partial response 22 (39.3) 7 (14.3) 29 (27.6)
 Stable disease 19 (33.9) 18 (36.7) 37 (35.2)
 Progressive disease 14 (25.0) 24 (49.0) 38 (36.2)
       
Overall response rate (%) 23/56 (41.1) 7/49 (14.3) P=0.002
Disease control rate (%) 42/56 (75.0) 25/49 (51.0) P=0.011

Abbreviations: D=docetaxel monotherapy; DS=docetaxel+sunitinib.